Foundry Partners LLC raised its stake in Nextgen Healthcare Inc (NASDAQ:NXGN) by 11.0% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 241,093 shares of the company’s stock after buying an additional 23,835 shares during the quarter. Foundry Partners LLC owned approximately 0.37% of Nextgen Healthcare worth $4,798,000 as of its most recent SEC filing.
A number of other hedge funds also recently bought and sold shares of the business. Parallel Advisors LLC bought a new stake in shares of Nextgen Healthcare during the first quarter valued at about $26,000. PNC Financial Services Group Inc. raised its stake in shares of Nextgen Healthcare by 37.3% during the fourth quarter. PNC Financial Services Group Inc. now owns 2,387 shares of the company’s stock valued at $36,000 after purchasing an additional 649 shares in the last quarter. MERIAN GLOBAL INVESTORS UK Ltd bought a new stake in shares of Nextgen Healthcare during the first quarter valued at about $109,000. Convergence Investment Partners LLC bought a new stake in shares of Nextgen Healthcare during the first quarter valued at about $152,000. Finally, Squarepoint Ops LLC bought a new stake in shares of Nextgen Healthcare during the fourth quarter valued at about $179,000. Institutional investors own 69.52% of the company’s stock.
NXGN traded down $0.05 during trading on Wednesday, reaching $16.49. The company had a trading volume of 12,191 shares, compared to its average volume of 349,635. The company has a current ratio of 1.21, a quick ratio of 1.21 and a debt-to-equity ratio of 0.13. The firm has a market capitalization of $1.08 billion, a P/E ratio of 27.03, a price-to-earnings-growth ratio of 2.93 and a beta of 1.03. Nextgen Healthcare Inc has a 12-month low of $13.89 and a 12-month high of $23.73. The company has a 50-day moving average of $19.17.
In other Nextgen Healthcare news, Director George H. Bristol sold 13,873 shares of the firm’s stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $19.25, for a total value of $267,055.25. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Sheldon Razin sold 4,018 shares of the firm’s stock in a transaction dated Thursday, June 13th. The stock was sold at an average price of $19.06, for a total transaction of $76,583.08. The disclosure for this sale can be found here. Insiders sold 19,004 shares of company stock worth $364,819 over the last three months. 18.50% of the stock is owned by insiders.
NXGN has been the topic of a number of research analyst reports. TheStreet raised BlackRock TCP Capital from a “c+” rating to a “b” rating in a report on Tuesday, May 28th. Zacks Investment Research lowered Comfort Systems USA from a “hold” rating to a “sell” rating in a report on Tuesday. Svb Leerink raised Nextgen Healthcare from a “market perform” rating to an “outperform” rating and lifted their target price for the stock from $19.00 to $22.00 in a report on Thursday, April 25th. Leerink Swann raised Nextgen Healthcare from a “market perform” rating to an “outperform” rating in a report on Thursday, April 25th. Finally, Dougherty & Co lowered Nextgen Healthcare from a “neutral” rating to a “sell” rating in a report on Thursday, July 25th. Three analysts have rated the stock with a sell rating, two have given a hold rating and three have issued a buy rating to the company. Nextgen Healthcare presently has an average rating of “Hold” and an average price target of $18.83.
Nextgen Healthcare Company Profile
NextGen Healthcare, Inc provides software, services, and analytics solutions to medical and dental group practices in the United States. The company's principal products include NextGen Enterprise EHR, which stores and maintains clinical patient information; and a workflow module, prescription management, automatic document and letter generation, patient education, referral tracking, interfaces to billing and lab systems, physician alerts and reminders, and reporting and data analysis tools.
See Also: Why are gap-down stocks important?
Receive News & Ratings for Nextgen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nextgen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.